Meet St. Jude’s tech transfer experts who patent and license researchers’ basic science discoveries to help patients worldwide.
St. Jude Global Academy hosted a neuro-oncology seminar to generate new ideas for high-impact interventions and share experiences. Read more.
Ending the HIV Epidemic is a bold plan to reduce HIV infections by 90 percent nationally. On a local level, St. Jude aims to have no new HIV cases by 2030.
Read how St. Jude researchers and clinicians used gene therapy to cure the diabolical bubble boy disease.
Sequencing data gives insights into what’s going on in a cell. It’s a lot of information. Read how scientists are finding ways to cut through the information and find causes for disease.
Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.
As clinicians learn more about the late effects of pediatric cancer treatments, these important discussions with patients are changing.
Researchers have promising information that ruxolitinib may help treat a devastating auto-immune disorder.